94 related articles for article (PubMed ID: 23645237)
1. [Velocity vector imaging assessment of early epirubicin-induced myocardial damage].
Jiang Y; Zhou Q; Tang Z; Peng Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):376-82. PubMed ID: 23645237
[TBL] [Abstract][Full Text] [Related]
2. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients.
Bi X; Deng Y; Zeng F; Zhu Y; Wu Y; Zhao C; Li C
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):391-4. PubMed ID: 19513629
[TBL] [Abstract][Full Text] [Related]
4. Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy.
Cadeddu C; Piras A; Dessì M; Madeddu C; Mantovani G; Scartozzi M; Hagendorff A; Colonna P; Mercuro G
Int J Cardiovasc Imaging; 2017 Feb; 33(2):197-207. PubMed ID: 27696298
[TBL] [Abstract][Full Text] [Related]
5. Assessment of early epirubicin cardiotoxicity in women with breast cancer.
Sobić-Saranović D; Pavlović S; Susnjar S; Neskovi c-Konstantinović Z; Jelić S
Anticancer Res; 1997; 17(5B):3889-91. PubMed ID: 9427798
[TBL] [Abstract][Full Text] [Related]
6. Study of Regional Left Ventricular Longitudinal Function in Fetuses with Gestational Diabetes Mellitus by Velocity Vector Imaging.
Wang X; Lian Y; Wang X; Tian M
Echocardiography; 2016 Aug; 33(8):1228-33. PubMed ID: 27460645
[TBL] [Abstract][Full Text] [Related]
7. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.
Jurcut R; Wildiers H; Ganame J; D'hooge J; De Backer J; Denys H; Paridaens R; Rademakers F; Voigt JU
J Am Soc Echocardiogr; 2008 Dec; 21(12):1283-9. PubMed ID: 19041569
[TBL] [Abstract][Full Text] [Related]
8. Early assessment of the left ventricular function by epirubicin-induced cardiotoxicity in postoperative breast cancer patients.
Luo R; Cui H; Huang D; Li G
Echocardiography; 2017 Nov; 34(11):1601-1609. PubMed ID: 28895191
[TBL] [Abstract][Full Text] [Related]
9. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines.
Radulescu D; Pripon S; Radulescu LI; Duncea C
Acta Cardiol; 2008 Feb; 63(1):27-32. PubMed ID: 18372577
[TBL] [Abstract][Full Text] [Related]
11. Myocardial function in patients with breast cancer after therapy with anthracyclines and chest irradiation.
Radulescu D; Pripon S; Parv A; Duncea C; Ciuleanu TE; Radulescu LI
J BUON; 2007; 12(3):349-52. PubMed ID: 17918288
[TBL] [Abstract][Full Text] [Related]
12. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer.
Zhang H; Shen WS; Gao CH; Deng LC; Shen D
Drugs R D; 2012 Jun; 12(2):101-6. PubMed ID: 22770377
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.
Appel JM; Sogaard P; Mortensen CE; Skagen K; Nielsen DL
J Am Soc Echocardiogr; 2011 Feb; 24(2):200-6. PubMed ID: 21227647
[TBL] [Abstract][Full Text] [Related]
15. Progressive subclinical left ventricular systolic dysfunction in severe aortic regurgitation patients with normal ejection fraction: a 24 months follow-up velocity vector imaging study.
Yurdakul S; Tayyareci Y; Yildirimturk O; Behramoglu F; Colakoglu Z; Memic K; Aytekin V; Aytekin S
Echocardiography; 2011 Sep; 28(8):886-91. PubMed ID: 21906163
[TBL] [Abstract][Full Text] [Related]
16. Assessment of left ventricular wall motion in diabetic rats using velocity vector imaging combined with stress echocardiography.
Wei Z; Su H; Zhang H; Zhou X; Zhu T; Liu L; Zhu Y; He G; Tian Q; Zhang J
Echocardiography; 2008 Jul; 25(6):609-16. PubMed ID: 18485011
[TBL] [Abstract][Full Text] [Related]
17. Detection of regional myocardial dysfunction in patients with acute myocardial infarction using velocity vector imaging.
Jurcut R; Pappas CJ; Masci PG; Herbots L; Szulik M; Bogaert J; Van de Werf F; Desmet W; Rademakers F; Voigt JU; D'hooge J
J Am Soc Echocardiogr; 2008 Aug; 21(8):879-86. PubMed ID: 18356019
[TBL] [Abstract][Full Text] [Related]
18. Assessment of regional myocardial function in patients with dilated cardiomyopathy by velocity vector imaging.
Zeng S; Zhou QC; Peng QH; Cao DM; Tian LQ; Ao K; Liang X
Echocardiography; 2009 Feb; 26(2):163-70. PubMed ID: 19054025
[TBL] [Abstract][Full Text] [Related]
19. Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?
Radulescu D; Buzdugan E; Ciuleanu TE; Todor N; Stoicescu L
J BUON; 2013; 18(4):1052-7. PubMed ID: 24344038
[TBL] [Abstract][Full Text] [Related]
20. Altered left ventricular diastolic performance in oncologic patients treated with epirubicin.
Radulescu D; Pripon S; Parv A; Duncea C; Ciuleanu TE
Congest Heart Fail; 2007; 13(4):215-20. PubMed ID: 17673874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
